Renaissance Tech Amends Medifast Stake (SC 13G/A)
Ticker: MED · Form: SC 13G/A · Filed: Feb 13, 2024 · CIK: 910329
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**Renaissance Tech just updated its Medifast holdings, watch for potential ripple effects.**
AI Summary
Renaissance Technologies LLC, a prominent investment firm, filed an amended SC 13G/A on February 13, 2024, indicating a change in their ownership of Medifast, Inc. (NYSE: MED) common stock as of December 29, 2023. This filing, Amendment No. 8, updates their previous disclosures regarding their stake in the health and wellness company. For investors, this matters because Renaissance Technologies is a sophisticated quantitative hedge fund, and changes in their holdings can signal shifts in their algorithmic outlook on Medifast's future performance, potentially influencing other institutional investors.
Why It Matters
This filing shows an update to a significant institutional investor's position in Medifast, which can be a signal of their confidence (or lack thereof) in the company's prospects.
Risk Assessment
Risk Level: low — An SC 13G/A filing is a routine disclosure of ownership changes by passive investors and typically does not indicate immediate high risk.
Analyst Insight
Investors should note that a change in a major institutional holder's position, especially from a firm like Renaissance Technologies, warrants further investigation into Medifast's recent performance and future outlook to understand the rationale behind the adjustment.
Key Players & Entities
- Renaissance Technologies LLC (company) — the investment firm filing the SC 13G/A
- Medifast, Inc. (company) — the subject company whose shares are being reported
- December 29, 2023 (date) — the date of the event requiring the filing
- February 13, 2024 (date) — the date the SC 13G/A was filed
- Amendment No. 8 (number) — the specific amendment number of the filing
Forward-Looking Statements
- Other quantitative funds may review Renaissance Technologies' updated position in Medifast, potentially leading to similar adjustments in their own portfolios. (Medifast, Inc.) — medium confidence, target: Q1 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing under the Securities Exchange Act of 1934.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is Renaissance Technologies LLC, located at 800 Third Ave, New York, NY.
What is the subject company of this filing?
The subject company is Medifast, Inc., with a business address at 11445 Cronhill Drive, Owings Mills, MD.
What is the CUSIP number for the class of securities reported?
The CUSIP number for the Common Stock, par value $0.001 per share, of Medifast, Inc. is 58470H101.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 29, 2023.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 13, 2024 regarding MEDIFAST INC (MED).